Becton Dickinson settles charges over infusion pump risks, SEC says
The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) over allegations it misled investors about risks associated with its Alaris infusion pump.
Becton, Dickinson to pay $175M to settle claims over misleading investors
The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued sales of and the costs of correcting software flaws associated with the company's Alaris infusion pump.
BD to pay $175M to settle charges of misleading investors on Alaris pump
BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said.
Becton Dickinson to Pay $175 Million to Settle SEC Probe
Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important products.
Becton Dickinson to Pay $175 Million Fine Related to SEC Investigation
Becton Dickinson has agreed to pay a $175 million fine to settle an investigation by the U.S. Securities and Exchange Commission. The previously disclosed investigation was related to the medical technology company's Alaris System,
Becton Dickinson to pay $175M to settle SEC probe
The SEC said Becton Dickinson failed to inform investors about the risks of a flawed infusion pump it manufactured that wouldn't obtain FDA approval.
MassDevice18h
BD to pay SEC $175M to settle Alaris investigation
BD (NYSE: BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system.
Yahoo Finance4d
FDA issues first early alert with Fresenius Kabi infusion pump recall
According to the notice, if a pneumatic valve fails, a pump problem alarm will be raised, which could potentially delay or ...
BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System Investigation
Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S.
drugdeliverybusiness6d
Fresenius Kabi warns on Ivenix infusion pump valves
The FDA said Fresenius Kabi told customers to remove its Ivenix large-volume infusion pumps from use for repair.
Implantable Infusion Pumps Market Insights, Competitive Landscape and Market Forecast to 2030
Some of the key market players operating in the implantable infusion pump market include Medtronic, Flowonix Medical, Intera Oncology, Tandem Diabetes Care, United Therapeutics, ICU Medical, Johnson & ...
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
We are honored to be included for the second consecutive year on Forbes’ List of America’s Most Successful Small-Cap ...